Phosphospecific antibodies recognising tau
US9540434B2 · kind B2 · utility
5Cited by
2References
17Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 5, 2012 |
| Grant date | Jan 10, 2017 |
| Priority date | — |
| Expiry date | Oct 5, 2032 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to methods and compositions for the therapeutic and diagnostic use in the treatment of diseases and disorders which are caused by or associated with neurofibrillary tangles, in particular, the invention relates to antibodies, which specifically recognize and bind to phosphorylated pathological protein tau-conformers and to methods and compositions involving said antibodies for the therapeutic and diagnostic use in the treatment of tauopathies including Alzheimer's Disease (AD).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.